Semaglutide Palm Beach Gardens, FL
Losing weight can become frustrating when your appetite, metabolism, and progress seem determined to work from three different playbooks. Semaglutide offers another way forward. This once-weekly medication works with the same cellular pathways involved in appetite, digestion, and blood sugar regulation, giving many patients the support they need as they build healthier routines and work toward sustainable weight loss.
At Aesthetics by Kallee, semaglutide in Palm Beach Gardens is prescribed within a medically supervised weight management program. Your plan is built around your health history, goals, response to treatment, and the habits that will help you maintain your progress.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics a naturally occurring hormone that helps with appetite control, food intake, digestion, and blood sugar regulation.
Semaglutide is the active ingredient in several prescription medications, including FDA-approved products used for chronic weight management, type 2 diabetes, cardiovascular risk reduction in certain patients, and other specific medical indications.
For weight management, semaglutide is intended to work alongside nutrition, physical activity, and ongoing medical care rather than functioning as a stand-alone solution.
Semaglutide activates the GLP-1 receptor, influencing several processes involved in hunger and metabolism.
One of its most noticeable effects is reducing appetite. Meals may feel satisfying sooner, and that sense of fullness may last longer. Semaglutide also slows gastric emptying, meaning food moves through the stomach more gradually. Together, these effects can make it easier to reduce food intake without constantly battling hunger. GLP-1 activity also affects insulin release and blood sugar control. In appropriate patients, this can support metabolic health alongside changes in body weight.
The medication does not physically burn fat or override nutrition, but it creates a biological environment that can make consistent dietary and lifestyle changes much easier to maintain.
For the right patient, semaglutide can provide valuable support throughout a weight loss program. Potential benefits include:
Clinical trials of semaglutide have demonstrated significant weight reduction when treatment is combined with a reduced-calorie diet and increased physical activity.
You may be a candidate for semaglutide if excess weight is affecting your health or quality of life and lifestyle changes alone have not produced sustainable results.
Body mass index is one factor considered when prescribing weight-loss medication. FDA-approved semaglutide for chronic weight management is indicated for certain adults with obesity or adults who are overweight and have at least one weight-related medical problem, such as high blood pressure, high cholesterol, or cardiovascular disease.
Your candidacy also depends on your medical history, current medications, prior weight-loss treatments, and overall health.
Semaglutide is not appropriate for everyone. It should not be used by patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.
Your provider will also need to know about a history of pancreatitis, severe stomach problems, diabetic retinopathy, gallbladder disease, kidney disease, pregnancy, previous allergic reactions to semaglutide, or other significant medical conditions.
If you take insulin, medications that stimulate insulin release, prescription drugs, supplements, or over-the-counter medications, these should also be reviewed for potential interactions and safety considerations.
Your program begins with an individualized consultation and health assessment. If semaglutide is appropriate, you’ll receive instructions for your specific medication, injection dosage form, and dosing schedule. Semaglutide is typically given as a subcutaneous injection once weekly. Depending on the prescribed product and instructions, common injection areas may include the abdomen, thigh, or upper arm.
Treatment usually begins at a lower dose, then is increased gradually as tolerated, giving your body time to adjust and helping reduce gastrointestinal side effects. Follow-up is an important part of treatment. We monitor your progress, appetite, side effects, body weight, and overall response before determining whether your dose should change.
The most common adverse effects involve the digestive system. Nausea, diarrhea, vomiting, constipation, indigestion, and stomach pain may occur, particularly as your dosage changes. Contact your healthcare provider promptly if you develop severe or persistent stomach pain, especially if it radiates toward your back, as this can be a sign of pancreatitis. Significant vomiting or diarrhea can also cause dehydration and may affect kidney function.
Low blood sugar is a greater concern for diabetic patients taking semaglutide alongside insulin or certain other diabetes medications. Seek immediate medical attention for symptoms of a serious allergic reaction, such as swelling or trouble breathing. Changes in vision should also be reported, particularly if you have diabetic retinopathy. Because semaglutide delays gastric emptying, tell your medical team that you take it before any surgery or procedure involving anesthesia or deep sedation due to the potential risk of pulmonary aspiration.
Some patients notice changes in appetite during the first several weeks, although meaningful weight loss develops gradually.
Your early doses are designed largely to help your body adjust. As treatment progresses and the dosage is increased appropriately, changes in appetite and body weight may become more apparent. Results can vary considerably between patients. Your starting weight, dose tolerance, food intake, activity, metabolic health, and consistency with treatment all influence your progress.
There is no universal finish line for semaglutide treatment.
Obesity and chronic weight management are long-term health issues, and stopping medication can allow appetite and weight gain to return. Some patients remain on treatment for an extended period, while other plans change as health goals, medication tolerance, and maintenance strategies evolve.
Kallee will monitor your progress and help determine what makes sense as you approach your target weight and move into maintenance.
Instructions for a missed dose depend on the specific semaglutide product you are using and how much time has passed.
Do not double your next scheduled dose to compensate. Contact Aesthetics by Kallee or follow the medication guide provided with your prescription for instructions on returning to your regular dosing schedule safely.
If several doses have been missed, your dosage may need to be adjusted before treatment resumes.
Aesthetics by Kallee currently lists a 2 mL semaglutide vial at $650, with additional costs for shipping and supplies. Your total weight loss program cost can vary according to your medication, dosage, treatment duration, follow-up needs, and any additional wellness support incorporated into your plan. We’ll review your recommended treatment and associated costs clearly before you begin.
Semaglutide is one of several medical options available for weight management. Tirzepatide is another injectable medication offered at Aesthetics by Kallee and works through both GIP and GLP-1 pathways.
Different patients respond differently to each medication. Your medical history, previous weight loss results, appetite patterns, side effects, metabolic health, and goals all help guide the decision.
A medically supervised program also allows treatment to evolve. The medication is one part of a larger strategy that includes nutrition, activity, monitoring, and realistic planning for weight maintenance.
Weight reduction can have benefits that extend beyond appearance. Excess weight is associated with medical problems including high blood pressure, high cholesterol, insulin resistance, cardiovascular disease, and type 2 diabetes. Those benefits apply to specific FDA-approved indications and patient populations, so your personal cardiovascular risk and treatment goals should be discussed individually.
Successful weight management needs more than access to medication. Kallee Sullivan, MMS, PA-C, approaches semaglutide treatment with medical oversight, ongoing education, and a clear understanding that patients require varying levels of support. Your progress is monitored over time rather than reduced to a number on the scale. Nutrition, medication tolerance, appetite changes, health history, lifestyle, and your long-term plan all influence how treatment is adjusted. That personalized approach gives you room to make progress at a pace that supports both your health and your ability to maintain the results.
Schedule your semaglutide consultation at Aesthetics by Kallee in Palm Beach Gardens, FL, to determine whether GLP-1 treatment fits into your personalized weight management plan.
Yes. Wegovy, which contains semaglutide, is FDA-approved for chronic weight management in specific patient populations when used with a reduced-calorie diet and increased physical activity. Semaglutide is also used in other FDA-approved medications for different indications.
Semaglutide can affect blood sugar, although significant hypoglycemia is more likely when it is combined with insulin or certain diabetes medications. Diabetic patients should discuss their current medications and blood sugar monitoring with their healthcare professional.
No medication can guarantee permanent weight loss. Appetite can increase, and weight may return after treatment is discontinued. Nutrition, physical activity, ongoing medical support, and a realistic maintenance strategy remain important.
Kidney disease does not automatically exclude every patient, but semaglutide requires careful medical consideration. Nausea, vomiting, or diarrhea can lead to dehydration and worsen kidney problems, so your kidney health should be reviewed before and during treatment.
Tell your surgeon, anesthesiologist, and other healthcare providers that you are taking semaglutide before a planned procedure. Because it delays gastric emptying, semaglutide has been associated with a risk of retained stomach contents and pulmonary aspiration during anesthesia or deep sedation.
Weight loss results vary substantially. Clinical trials show that semaglutide can produce significant average body weight reduction, but individual results depend on your starting point, treatment duration, dosage, diet and exercise habits, medication tolerance, and overall health.
